XRAY

Business Context and Reporting Period

Company: DENTSPLY International Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007
Business Overview: The world's largest manufacturer of professional dental products, operating in over 120 countries. The company serves the professional dental market with consumable products, laboratory products, implants, and orthodontic solutions. In January 2007, the company reorganized its operating structure into four reportable segments.

Key Financial Metrics

Margins: Gross profit margin was 52.1% of net sales (58.2% excluding precious metal content). Operating margin was 17.2%.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9.7% year-over-year. Excluding precious metal content, sales grew 10.4%, driven by 6.4% internal growth and 4.0% foreign currency translation. Internal growth was strongest in Europe (8.2%) and the U.S. (4.7%).
• Profitability: Net income rose 17.0% to $58.5 million. This was aided by a significant reduction in restructuring costs, which fell from $4.7 million in Q1 2006 to $1.0 million in Q1 2007.
• Expenses: Selling, general, and administrative (SG&A) expenses increased 12.8% to $164.1 million, primarily due to currency translation, costs associated with the biennial International Dental Show (IDS), and consolidation of U.S. divisions.
• Interest Income: Net interest income improved due to benefits from cross-currency swaps and lower average net debt levels, despite higher interest rates.
• Segment Performance: The "Global Dental Laboratory Business/Implants/Non-Dental" segment saw the highest operating income growth (19.7%), driven by the Implant business. The "France, U.K., Italy..." segment turned a loss of $1.3 million in 2006 into a profit of $0.6 million in 2007.

Guidance, Outlook, and Risks

• Outlook: Management targets a long-term sustainable internal growth rate of 4-6%. The company expects to introduce over 25 new products in 2007. Capital expenditures are projected to range between $60 million and $65 million for the full year.
• Capital Structure: In March 2007, the company issued $150 million in floating rate Senior Notes due 2010. The ratio of long-term debt to total capitalization increased to 23.6% from 22.4% at year-end 2006.
• Legal Proceedings:
  • Antitrust: Ongoing private party class actions regarding tooth distribution practices (Trubyte teeth) remain pending, though the Supreme Court denied a petition for review of a dismissal of most damage claims.
  • Product Liability: A class action regarding "Advance" cement has reached a preliminary settlement agreement pending a fairness hearing in June 2007. Separate class actions regarding "Cavitron" ultrasonic scalers are pending in California and Pennsylvania/New Jersey.
• Accounting Changes: The company adopted FIN 48 (Accounting for Uncertainty in Income Taxes) on January 1, 2007, resulting in a $3.8 million increase to reserves for uncertain tax positions.

Investor Verification Checklist

• Internal Growth Sustainability: Verify if the 6.4% internal growth rate (excluding currency and acquisitions) is sustainable given the cyclical nature of the dental market and the impact of the IDS trade show.
• Restructuring Completion: Confirm the timeline and remaining costs for the 2004, 2005, and 2006 restructuring plans, particularly the European Shared Services Center completion expected in early 2008.
• Legal Exposure: Assess the potential financial impact of the "Advance" cement settlement and the ongoing "Cavitron" litigation, including insurance coverage limits.
• Precious Metal Hedging: Review the effectiveness of commodity swaps and consignment agreements in mitigating risks associated with platinum and silver price volatility.
• Debt Servicing: Monitor the impact of the new $150 million floating rate notes on future interest expense, especially in a rising rate environment.